Company news
Zhejiang Conba Pharmaceutical Co., Ltd. Class A (SSE:600572) news
Zhejiang Conba Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Aug 16, 2025: Announcement on Shareholding Reduction Plan of through Call…
Press releases — page 2
Announcement on Shareholding Reduction Plan of through Call Auction by Shareholder
August 15, 2025
Indicative Announcement on the Change in Equity of Shareholders Holding More Than 5% and Their Persons Acting in Concert
August 5, 2025
Announcement on Subsidiary's Obtainment of Drug Registration Certificate for Tranexamic Acid Tablets
July 31, 2025
Announcement on Obtaining Drug Registration Certificate for Perindopril Amlodipine Tablets (III)
July 28, 2025
Announcement on Cancelling Implementation Result of Share Repurchase and Share Changes
July 8, 2025
Announcement on Voluntary Exercise Results of Stock Option Incentive Plan in Q2 2025 and Share Changes
July 1, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 18, 2025
Announcement on Adjusting the Exercise Price of Stock Options in the 2022 Stock Option Incentive Plan
June 13, 2025
Indicative Announcement on Adjustment of Restricted Exercise Period for the First Vesting Period of Stock Options Initially Granted in 2022 Stock Option Incentive Plan
June 11, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
June 10, 2025
Announcement on Obtaining Drug Registration Certificate for QingYanHouHanPian
May 27, 2025
Announcement on Cancellation of the Repurchased Shares, Reduction of Registered Capital and Notification to Creditors
May 23, 2025